News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
201,057 Results
Type
Article (19837)
Company Profile (110)
Press Release (181110)
Section
Business (64686)
Career Advice (812)
Deals (9159)
Drug Delivery (72)
Drug Development (19764)
Employer Resources (137)
FDA (3440)
Job Trends (6018)
News (97257)
Policy (7253)
Tag
Academia (1522)
Alliances (17619)
Alzheimer's disease (504)
Antibody-drug conjugate (ADC) (47)
Approvals (3415)
Artificial intelligence (77)
Bankruptcy (46)
Best Places to Work (4900)
Biotechnology (68)
Breast cancer (55)
Cancer (404)
Cardiovascular disease (42)
Career advice (715)
CAR-T (42)
Cell therapy (104)
Clinical research (14728)
Collaboration (214)
COVID-19 (1037)
C-suite (62)
Data (423)
Diabetes (48)
Diagnostics (2337)
Earnings (14630)
Employer resources (117)
Events (29666)
Executive appointments (189)
FDA (3603)
Funding (191)
Gene therapy (75)
GLP-1 (281)
Government (1344)
Healthcare (5039)
Infectious disease (1079)
Inflammatory bowel disease (46)
Interviews (113)
IPO (3692)
Job creations (1307)
Job search strategy (631)
Layoffs (146)
Legal (1194)
Lung cancer (66)
Manufacturing (94)
Medical device (2673)
Medtech (2678)
Mergers & acquisitions (5571)
Metabolic disorders (160)
Neuroscience (618)
NextGen Class of 2024 (2132)
Non-profit (1682)
Northern California (524)
Obesity (107)
Opinion (88)
People (26752)
Phase I (4418)
Phase II (6144)
Phase III (5727)
Pipeline (125)
Postmarket research (577)
Preclinical (2531)
Press Release (61)
Radiopharmaceuticals (83)
Rare diseases (82)
Real estate (2547)
Recruiting (53)
Regulatory (5102)
Research institute (1281)
Resumes & cover letters (106)
Southern California (350)
Startups (2014)
United States (4390)
Vaccines (189)
Weight loss (84)
Date
Today (39)
Last 7 days (220)
Last 30 days (858)
Last 365 days (11729)
2024 (11381)
2023 (13289)
2022 (16150)
2021 (18202)
2020 (16795)
2019 (15325)
2018 (11073)
2017 (10591)
2016 (10417)
2015 (11177)
2014 (8265)
2013 (7183)
2012 (7610)
2011 (7833)
2010 (7285)
Location
Africa (324)
Arizona (54)
Asia (11318)
Australia (1965)
California (1054)
Canada (428)
China (86)
Colorado (60)
Connecticut (48)
Delaware (50)
Europe (29300)
Florida (142)
Illinois (98)
Indiana (95)
Maryland (139)
Massachusetts (875)
Michigan (68)
Minnesota (89)
New Jersey (343)
New York (404)
North Carolina (252)
Northern California (524)
Ohio (48)
Pennsylvania (172)
South America (395)
Southern California (350)
Texas (151)
Washington State (94)
201,057 Results for "particle sciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Global CDMO Agno Pharma Completes Acquisition of Particle Sciences Inc.
Agno Pharma, a US-based, global pharmaceutical contract development and manufacturing organization, announced that it will acquire the Lubrizol Particle Sciences Inc. business.
December 18, 2023
·
2 min read
Genetown
Fluent Biosciences announces early access availability of transformative direct-guide capture for single cell analysis for complex CRISPR screening in Particle-templated Instant Partitions (PIPseq-CRISPR)
Fluent BioSciences, a life sciences company focused on making single-cell analysis simple and accessible to every researcher, announces early access availability of new kits and reagents for direct CRISPR guide capture in particle templated instant partitions (PIPseq-CRISPR).
March 21, 2024
·
1 min read
Press Releases
Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter
November 8, 2024
·
7 min read
Biotech Beach
Cytek® Biosciences Adds Ability to Detect Subcellular Particles to Its Industry-Leading Cell Analysis Systems
Cytek Biosciences, Inc., a leading cell analysis solutions company, officially announced its Enhanced Small Particle Detection Option for its flagship Cytek Aurora™ and Cytek Northern Lights™ cell analysis systems.
May 20, 2024
·
8 min read
Genetown
Nvelop Therapeutics to Share the First Preclinical Data from its Novel, Humanized Particle Platform for In Vivo Delivery of Genetic Cargoes at the ASGCT Annual Meeting
Nvelop Therapeutics to Share the First Preclinical Data from its Novel, Humanized Particle Platform for In Vivo Delivery of Genetic Cargoes at the ASGCT Annual Meeting.
May 9, 2024
·
3 min read
Genetown
Particles for Humanity Receives Approval to Begin a Study of PFH-VAP in Humans
Particles for Humanity has received approval from the Institutional Review Board (IRB) at the University of Wisconsin-Madison in the United States to begin a human absorption study of PFH-VAP, a stable form of vitamin A.
December 12, 2023
·
2 min read
Press Releases
Merck Animal Health Announces Expansion of NOBIVAC® NXT Platform with the First and Only RNA-Particle Technology Vaccine for Feline Leukemia Virus
September 25, 2024
·
5 min read
Job Creations
Massachusetts Increases Life Sciences Investment by $500M Over 10 Years
Massachusetts’ increased investment in the life sciences industry includes boosting its life sciences tax incentive program by $10 million annually, aiding job creation in the state.
November 21, 2024
·
2 min read
·
Angela Gabriel
BioMidwest
Particle Dynamics Announces Anish Parikh as New Chief Commercial Officer
Particle Dynamics, a leader in oral solid dosage technologies for the pharmaceutical sector, has appointed Anish Parikh as its Chief Commercial Officer.
August 25, 2023
·
2 min read
Genetown
Biognosys launches groundbreaking P2 Plasma Enrichment technology for unbiased, deep plasma proteomics at ASMS 2024
Biognosys, a leader in next-generation proteomics services, software and kits for life sciences research and drug development, announced the launch of the novel, proprietary P2 Plasma Enrichment method for single-well, single particle-type enrichment with market leading performance and sensible, superior economics.
May 30, 2024
·
6 min read
1 of 20,106
Next
